Karyopharm Therapeutics, Inc. (KPTI)
8.58
-0.36
(-4.03%)
USD |
NASDAQ |
Feb 13, 16:00
8.60
+0.02
(+0.23%)
After-Hours: 20:00
Karyopharm Therapeutics Shareholders Equity (Quarterly) : -292.93M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Baxter International, Inc. | 6.129B |
| Bruker Corp. | 2.474B |
| Catalyst Pharmaceuticals, Inc. | 920.24M |
| Agios Pharmaceuticals, Inc. | 1.193B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 108.42M |
| Total Liabilities (Quarterly) | 401.34M |
| Debt to Equity Ratio | -0.7746 |
| Current Ratio | 1.030 |
| Net Debt Paydown Yield | -5.20% |